We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
51
Cognizant
CTSH
$21.5B
$9.28M 0.34%
148,222
+139,249
+1,552% +$8.74M
RHT
52
DELISTED
Red Hat Inc
RHT
$9.2M 0.34%
128,028
+21,032
+20% +$1.58M
CSCO icon
53
Cisco
CSCO
$450B
$9.13M 0.34%
+347,652
New +$9.39M
APD icon
54
Air Products & Chemicals
APD
$66.3B
$9.02M 0.33%
+76,433
New +$9.73M
CPN
55
DELISTED
Calpine Corporation
CPN
$8.98M 0.33%
615,450
+279,728
+83% +$4.59M
DFS
56
DELISTED
Discover Financial Services
DFS
$8.93M 0.33%
171,746
+118,127
+220% +$6.48M
LLY icon
57
Eli Lilly
LLY
$1.07T
$8.85M 0.33%
+105,796
New +$8.93M
HOT
58
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$8.83M 0.33%
132,800
-86,835
-40% -$6.6M
REGN icon
59
Regeneron Pharmaceuticals
REGN
$68.8B
$8.72M 0.32%
18,752
+12,946
+223% +$6.95M
ABMD
60
DELISTED
Abiomed Inc
ABMD
$8.63M 0.32%
93,003
-5,680
-6% -$500K
SIG icon
61
Signet Jewelers
SIG
$3.55B
$8.61M 0.32%
63,253
-3,063
-5% -$393K
CB
62
DELISTED
CHUBB CORPORATION
CB
$8.28M 0.31%
+67,478
New +$8.26M
ANDV
63
DELISTED
Andeavor
ANDV
$8.23M 0.3%
84,625
+81,001
+2,235% +$7.87M
BURL icon
64
Burlington
BURL
$22B
$8.15M 0.3%
159,791
+111,191
+229% +$5.94M
AVGO icon
65
Broadcom
AVGO
$1.82T
$8.15M 0.3%
652,110
+384,890
+144% +$4.86M
LVLT
66
DELISTED
Level 3 Communications Inc
LVLT
$8.11M 0.3%
185,647
-19,292
-9% -$929K
BSX icon
67
Boston Scientific
BSX
$65.8B
$8.11M 0.3%
494,108
+334,201
+209% +$5.71M
CHKP icon
68
Check Point Software Technologies
CHKP
$13.3B
$8.1M 0.3%
102,139
+87,535
+599% +$6.99M
MGM icon
69
MGM Resorts International
MGM
$11.7B
$7.95M 0.29%
430,985
-167,010
-28% -$3.34M
NVDA icon
70
NVIDIA
NVDA
$5.01T
$7.95M 0.29%
+12,902,600
New +$6.98M
NFX
71
DELISTED
Newfield Exploration
NFX
$7.77M 0.29%
236,289
+152,286
+181% +$5.11M
PHM icon
72
Pultegroup
PHM
$24.5B
$7.62M 0.28%
403,739
-2,118
-0.5% -$43.1K
ZION icon
73
Zions Bancorporation
ZION
$10.1B
$7.57M 0.28%
274,847
+167,371
+156% +$4.96M
CPGX
74
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
$7.57M 0.28%
+413,672
New +$10.8M
MCK icon
75
McKesson
MCK
$98.5B
$7.57M 0.28%
40,890
-19,176
-32% -$4.06M

Similar funds

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.